Remove en acute-health-threats
article thumbnail

ZOLL and CAIRE, Inc. Sign Exclusive Agreement for Outside-the-U.S. Distribution of Portable Oxygen Concentrator

The Pharma Data

By combining the EMV+ ventilator with the SAROS 4000 Oxygen Concentrator, remote medics will be able to deliver high-end, oxygen-enriched critical care ventilation and oxygenation therapy without the use of oxygen cylinders, which present refilling and logistical challenges and are a hazardous threat in armed conflicts. ZOLL and the Military.

Reagent 52
article thumbnail

COVID-19 Pandemic Coverage

XTalks

By the end of August, the World Health Organization (WHO) counted 33 vaccine candidates in some stage of clinical trial evaluation. The National Institutes of Health in the US recently announced it was putting several million dollars toward a convalescent plasma trial. Update: July 27, 2020. Economic Impact: Global.